Johnson & Johnson Innovative Medicine has strengthened its commitment in Italy, with a projected investment of €580 million over the next five years, of which €125 million will support an increase in production capacity and build capabilities for the future. The investment is part of a strategic plan that has included a 9.2 percent investment growth each year between 2019-2023 in Italy, which is three times greater than the pharmaceutical sector average, according to a new study by The E...